Lonza Group Future Growth
Future criteria checks 4/6
Lonza Group is forecast to grow earnings and revenue by 23.9% and 11.7% per annum respectively. EPS is expected to grow by 23.8% per annum. Return on equity is forecast to be 13.3% in 3 years.
Key information
23.9%
Earnings growth rate
23.8%
EPS growth rate
Life Sciences earnings growth | 19.4% |
Revenue growth rate | 11.7% |
Future return on equity | 13.3% |
Analyst coverage | Good |
Last updated | 20 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 8,783 | 1,360 | 456 | 2,158 | 18 |
12/31/2025 | 7,842 | 1,109 | 115 | 1,663 | 21 |
12/31/2024 | 6,686 | 848 | -85 | 1,520 | 21 |
6/30/2024 | 6,696 | 573 | -30 | 1,524 | N/A |
3/31/2024 | 6,707 | 614 | -169 | 1,456 | N/A |
12/31/2023 | 6,717 | 654 | -309 | 1,388 | N/A |
9/30/2023 | 6,518 | 892 | -532 | 1,239 | N/A |
6/30/2023 | 6,319 | 1,129 | -756 | 1,089 | N/A |
3/31/2023 | 6,271 | 1,172 | -828 | 1,055 | N/A |
12/31/2022 | 6,223 | 1,215 | -901 | 1,020 | N/A |
9/30/2022 | 6,036 | 1,062 | -819 | 994 | N/A |
6/30/2022 | 5,849 | 909 | -737 | 968 | N/A |
3/31/2022 | 5,629 | 792 | -450 | 1,093 | N/A |
12/31/2021 | 5,409 | 674 | -163 | 1,217 | N/A |
9/30/2021 | 5,108 | 612 | -2 | 1,233 | N/A |
6/30/2021 | 4,807 | 550 | 159 | 1,249 | N/A |
3/31/2021 | 4,658 | 640 | 150 | 1,190 | N/A |
12/31/2020 | 4,508 | 730 | 140 | 1,130 | N/A |
9/30/2020 | 3,135 | 656 | 236 | 1,181 | N/A |
6/30/2020 | 3,474 | 696 | 344 | 1,241 | N/A |
3/31/2020 | 3,841 | 672 | 266 | 1,109 | N/A |
12/31/2019 | 4,207 | 647 | 188 | 977 | N/A |
9/30/2019 | 5,821 | 710 | N/A | N/A | N/A |
6/30/2019 | 5,722 | 658 | 117 | 821 | N/A |
3/31/2019 | 5,632 | 657 | 312 | 952 | N/A |
12/31/2018 | 5,542 | 655 | 506 | 1,082 | N/A |
6/30/2018 | 5,034 | 826 | 378 | 860 | N/A |
3/31/2018 | 4,791 | 745 | N/A | 851 | N/A |
12/31/2017 | 4,548 | 664 | N/A | 841 | N/A |
9/30/2017 | 4,758 | 527 | N/A | 798 | N/A |
6/30/2017 | 4,423 | 334 | N/A | 738 | N/A |
3/31/2017 | 4,278 | 318 | N/A | 745 | N/A |
12/31/2016 | 4,132 | 301 | N/A | 752 | N/A |
9/30/2016 | 4,025 | 331 | N/A | 779 | N/A |
6/30/2016 | 3,918 | 360 | N/A | 805 | N/A |
3/31/2016 | 3,861 | 319 | N/A | 773 | N/A |
12/31/2015 | 3,803 | 277 | N/A | 741 | N/A |
9/30/2015 | 3,774 | 243 | N/A | 710 | N/A |
6/30/2015 | 3,744 | 208 | N/A | 678 | N/A |
3/31/2015 | 3,692 | 223 | N/A | 581 | N/A |
12/31/2014 | 3,640 | 237 | N/A | 483 | N/A |
9/30/2014 | 3,640 | 212 | N/A | 534 | N/A |
6/30/2014 | 3,640 | 186 | N/A | 584 | N/A |
3/31/2014 | 3,612 | 137 | N/A | 553 | N/A |
12/31/2013 | 3,584 | 87 | N/A | 522 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0QNO's forecast earnings growth (23.9% per year) is above the savings rate (2.1%).
Earnings vs Market: 0QNO's earnings (23.9% per year) are forecast to grow faster than the UK market (14.6% per year).
High Growth Earnings: 0QNO's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 0QNO's revenue (11.7% per year) is forecast to grow faster than the UK market (3.5% per year).
High Growth Revenue: 0QNO's revenue (11.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0QNO's Return on Equity is forecast to be low in 3 years time (13.3%).